Clinical Trial Update: Study In Airway Physiology In Children SERETIDE DISKUS ® Inhlaer and FLIXOTIDE® Inhaler Are Trademarks of GSK Group of Companies. [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update for asthma in children evaluating Seretide Diskus Inhaler (salmeterol xinafoate / fluticasone propionate) and Flixotide Inhaler (f…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• FLIXOTIDE Inhaler (fluticasone propionate)
• Seretide Diskus Inhaler (salmeterol xinafoate / fluticasone propionate)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Asthma | Phase 4 | Status: COMPLETED